Related Experiment Video
Updated: Feb 28, 2026

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Core Ferroptosis-Related Biomarkers and miRNA Regulatory Networks in Alzheimer's Disease
Wenjia Liu1, Xin Rao2, Liyang Yu2
1School of Electronic Information Engineering, Suzhou Polytechnic University, Suzhou 215104, China.
Abstract:
Background: The exact pathogenesis of Alzheimer's disease (AD), a neurodegenerative disorder, remains unclear. Ferroptosis is a form of cell death characterized by intracellular iron accumulation, and has emerged as a potential contributor to the pathological cascade of AD. Therefore, this study aims to identify core genes that may function as reliable biomarkers for AD through an in-depth analysis of the genetic relationship between ferroptosis-related genes and AD. Methods: This study first obtained the gene expression profiles (GSE140831, GSE63060 and GSE63061 expression profiles). The GSE140831 dataset served as the discovery cohort, and the GSE63060 and GSE63061 datasets were used as independent validation cohorts. R language 4.4.1 was used for standardizing and identifying differentially expressed genes (DEGs) in AD patients in all datasets. Secondly, the ferroptosis-related genes were obtained. By integrating the ferroptosis-related genes, ferroptosis-related DEGs (FRDEGs) were detected. Then, the FRDEGs were verified and evaluated, and the biological functions of the core genes were analyzed. Finally, miRNAs interacting with these core FRDEGs were explored. Results: The study identified nine FRDEGs (ACVR1B, BRPF1, G6PD, KLHDC3, LAMP2, MTCH1, P4HB, PTPN6, RBMS1), which are potentially related and may serve as biomarkers for AD. All nine genes demonstrated statistically significant differential expression (up-regulation) in both independent validation cohorts and in the combined analysis (p < 0.05). Although the area under the curve (AUC) values of these nine genes ranged from 0.61 to 0.71, indicating moderate discriminatory power, these findings suggest that they may be involved in pathways related to AD and are worthy of further investigation as potential auxiliary biomarkers. Finally, a network of hub FRDEGs-miRNAs interaction was constructed. There were 11 miRNAs that may regulate these hub FRDEGs simultaneously. Conclusions: This study showed the significant association of the identified FRDEGs with AD. Also, a core ferroptosis-related biomarker network for miRNAs regulation of AD was constructed. The specific regulatory mechanism is worthy of further investigation.
Insights
This study identifies nine ferroptosis-related differentially expressed genes (FRDEGs) as potential biomarkers for Alzheimer's disease (AD). These FRDEGs show significant differential expression in AD patients, suggesting their role in disease pathology and potential for diagnostic applications.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Alzheimer's disease (AD) pathogenesis remains unclear.
- Ferroptosis, an iron-dependent cell death, is implicated in AD.
- Identifying AD biomarkers is crucial for early diagnosis and treatment.
Purpose of the Study:
- To identify core ferroptosis-related genes (FRDEGs) associated with Alzheimer's disease.
- To evaluate the potential of these FRDEGs as reliable AD biomarkers.
- To explore the regulatory network of FRDEGs and microRNAs (miRNAs) in AD.
Main Methods:
- Analysis of gene expression profiles from AD patients (GSE140831, GSE63060, GSE63061).
- Identification of differentially expressed genes (DEGs) and ferroptosis-related DEGs (FRDEGs).
- Validation of FRDEGs and construction of a FRDEG-miRNA interaction network.
Main Results:
- Nine FRDEGs (ACVR1B, BRPF1, G6PD, KLHDC3, LAMP2, MTCH1, P4HB, PTPN6, RBMS1) were identified as potential AD biomarkers.
- All nine genes showed statistically significant up-regulation in AD patients (p < 0.05).
- A network of 11 miRNAs regulating these hub FRDEGs was constructed.
Conclusions:
- The identified FRDEGs are significantly associated with Alzheimer's disease.
- A core ferroptosis-related biomarker network involving miRNA regulation in AD was established.
- Further investigation into the specific regulatory mechanisms is warranted.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation
Alzheimer's Disease: Treatment
MicroRNAs

